Boussard & Gavaudan Investment Management’s Cytokinetics CYTK Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2023 Q4	–	Sell	-18,345	Closed	-$555K	–	79
2023 Q3	$555K	Buy	18,345 +2,800	+18%	+$84.7K	0.06%	69
2023 Q2	$517K	Buy	+15,545	New	+$517K	0.05%	79